Related Experiment Video
Updated: Feb 20, 2026

11:56
Generation of Mice Derived from Induced Pluripotent Stem Cells
Published on: November 29, 2012
22.3K
Rat embryonic stem cells produce fertile offspring through tetraploid complementation
Tian-Da Li1, Gui-Hai Feng1, Yu-Fei Li1,2
1State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Summary
Rat embryonic stem cells (ESCs) can produce fertile offspring via tetraploid complementation, demonstrating robust pluripotency. However, this ability is quickly lost during culture due to genomic imprinting loss.
Area of Science:
- Stem cell biology
- Developmental biology
- Genetics
Background:
- Embryonic stem cells (ESCs) possess pluripotency, crucial for development.
- Tetraploid complementation is the most rigorous test for assessing ESC pluripotency.
- The ability of non-murine ESCs to pass this test remains largely unexplored.
Purpose of the Study:
- To investigate the developmental potency of rat ESCs using tetraploid complementation.
- To determine if rat ESCs can generate a complete organism.
- To explore the stability of pluripotency in cultured rat ESCs.
Main Methods:
- Derivation of rat ESCs under specific 2i (two small molecule inhibitors) conditions.
- Assessment of pluripotency through tetraploid complementation.
- Analysis of genomic imprinting in cultured rat ESCs.
Main Results:
- Early-passage rat ESCs successfully produced fertile offspring via tetraploid complementation.
- Rat ESCs rapidly lost the capacity for tetraploid complementation upon further culture.
- This loss correlated with a near-complete erasure of genomic imprinting.
Conclusions:
- Naïve ground state pluripotency can be achieved in rat ESCs.
- Species-specific differences exist in the regulation and maintenance of pluripotency.
- Findings have implications for deriving and utilizing naïve pluripotent stem cells in various species, including humans.
Related Concept Videos
Zygotic Development And Stem Cell Formation
6.9K
The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
6.9K
Embryonic Stem Cells
32.9K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.9K
Embryonic Stem Cells
5.4K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.4K
Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K

